Cytoo (Grenoble, FRA) a commercial-stage medical device company focused on cell based assays, high content analysis and cell screening, closed a $10M Series C financing. Participants include Sham, Entrepreneurs Fund and Auriga Ventures.
Cyntellect (San Diego, CA) a commercial-stage medical device company focused on in situ, microplate-based cytometry cell analysis, closed a $9M Series E, bringing the total round to $16M. Participants were not disclosed.
Cytoo (France) a commercial-stage provider of adhesive micropattern-based chips, plates and chambers for cell analyses, closed a $4.7M Series B financing. Participants include Auriga Partners and CEA Investissement.